Renal function assessment in @entity955 : Usefulness of @entity740 epidemiology collaboration vs re-expressed 4 variable modification of diet in XXXX .

@entity1 @entity8 @entity548 @entity2067 @entity740 @entity1031 @entity955
AIM: To compare the performance of the re-expressed Modification of Diet in @entity8 equation vs the new @entity740 Epidemiology Collaboration equation in @entity1 with non-valvular @entity955 . METHODS: We studied 911 consecutive @entity1 with non-valvular @entity955 on @entity2067 antagonist. The performance of the re-expressed Modification of Diet in @entity8 equation vs the new @entity740 Epidemiology Collaboration equation in @entity1 with non-valvular @entity955 with respect to either a composite endpoint of major @entity548 , @entity1031 events and all-cause mortality or each individual component of the composite endpoint was assessed using continuous and categorical >=  60, 59-30, and < 30 mL/min per 1.73 m(2) estimated glomerular filtration rate. RESULTS: During 10    3 mo, the composite endpoint occurred in 98 (10.8%) @entity1 : 30 @entity1 developed major @entity548 , 18 had @entity1031 events, and 60 died. The new equation provided lower prevalence of @entity8 < 60 mL/min per 1.73 m(2) (32.9%), compared with the re-expressed equation (34.1%). Estimated glomerular filtration rate from both equations was independent predictor of composite endpoint (HR = 0.98 and 0.97 for the re-expressed and the new equation, respectively; P < 0.0001) and all-cause mortality (HR = 0.98 for both equations, P < 0.01). Strong association with @entity1031 events was observed only when estimated glomerular filtration rate was < 30 mL/min per 1.73 m(2): HR is 5.1 for the re-expressed equation, and HR = 5.0 for the new equation. No significant association with major @entity548 was observed for both equations. CONCLUSION: The new equation reduced the prevalence of @entity8 . Both equations performed similarly in predicting major adverse outcomes.
